Quantifying the natural history of biofilm formation in vivo during the establishment of chronic implant-associated Staphylococcus aureus osteomyelitis in mice to identify critical pathogen and host factors.
about
Biomaterials approaches to treating implant-associated osteomyelitis.Infectious Dose Dictates the Host Response during Staphylococcus aureus Orthopedic-Implant Biofilm Infection.Polymeric nanofiber coating with tunable combinatorial antibiotic delivery prevents biofilm-associated infection in vivoBiofilms in orthopedic infections: a review of laboratory methods.Silver Nanocoating Technology in the Prevention of Prosthetic Joint Infection.Critical review on biofilm methods.Antibacterial activity of a new broad-spectrum antibiotic covalently bound to titanium surfaces.Efficacy of Open Debridement and Polyethylene Exchange in Strictly Selected Patients with Infection after Total Knee Arthroplasty.Mouse model of hematogenous implant-related Staphylococcus aureus biofilm infection reveals therapeutic targets.[The significance of biofilm for the treatment of infections in orthopedic surgery : 2017 Update].Evidence of Staphylococcus Aureus Deformation, Proliferation, and Migration in Canaliculi of Live Cortical Bone in Murine Models of Osteomyelitis.Novel rat tail discitis model using bioluminescent Staphylococcus aureus.Obesity/type 2 diabetes increases inflammation, periosteal reactive bone formation and osteolysis during Staphylococcus aureus implant-associated bone infection.Unveiling and Characterizing Early Bilateral Interactions between Biofilm and the Mouse Innate Immune System.Surface topography of silicon nitride affects antimicrobial and osseointegrative properties of tibial implants in a murine model.Comparison of the immune response during acute and chronic Staphylococcus aureus infection.Coatings as the useful drug delivery system for the prevention of implant-related infections
P2860
Q36555710-25714A56-47B4-454C-BD95-C2AD2481FAD3Q37073985-37211C9A-7590-47DF-875E-8B18480CEB07Q37417976-B6F6591F-5747-4F58-A982-A6DF10A8CDF0Q38730718-99FE2AB2-2E96-4D7C-9DF4-4B66A5A4C01FQ38872187-603FA677-455E-4A23-A07A-2BE0493AF3F5Q39015075-B484452F-872D-4DFD-829A-EF6D39ED31ACQ39897961-0BEC89E3-E39E-47B3-B016-BABA31076AFBQ40074387-AD9B395B-7E09-4622-914B-DF0685707607Q40175177-329EF724-E77E-4356-A5BA-6824062BABB9Q40200018-1F8F3C0D-413D-412B-AD7D-3864F37F29E2Q40416910-67572CB4-198E-4FC5-B7AF-BD83900E341BQ40423679-C321B541-1FE3-4702-AE2C-B04B807A95FBQ46901804-D22C679A-9C5E-4560-A8D0-45C2A6214D6DQ47119043-37E11102-F6F0-4475-AD1B-515A99D06692Q47653172-1B2D225A-E4A8-4DB4-911C-86C11641D3A8Q54245850-F4F357AD-64FC-49B8-9487-C220C53BE7DBQ58768791-71D2C15F-7906-423E-8701-2EDC5AAB167F
P2860
Quantifying the natural history of biofilm formation in vivo during the establishment of chronic implant-associated Staphylococcus aureus osteomyelitis in mice to identify critical pathogen and host factors.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Quantifying the natural histor ...... cal pathogen and host factors.
@ast
Quantifying the natural histor ...... cal pathogen and host factors.
@en
type
label
Quantifying the natural histor ...... cal pathogen and host factors.
@ast
Quantifying the natural histor ...... cal pathogen and host factors.
@en
prefLabel
Quantifying the natural histor ...... cal pathogen and host factors.
@ast
Quantifying the natural histor ...... cal pathogen and host factors.
@en
P2093
P2860
P356
P1476
Quantifying the natural histor ...... ical pathogen and host factors
@en
P2093
Edward M Schwarz
Hiromu Ito
John J Varrone
John L Daiss
Karen L de Mesy Bentley
Kohei Nishitani
Sheila N Bello-Irizarry
Stephen L Kates
Werasak Sutipornpalangkul
P2860
P304
P356
10.1002/JOR.22907
P577
2015-05-18T00:00:00Z